THE RISK OF COLORECTAL CANCER IN PATIENTS WITH TYPE 2 DIABETES: ASSOCIATIONS WITH TREATMENT STAGE AND OBESITY

Aim: Colorectal risk of colon cancer in type 2 diabetic patients: correlations between treatment session and obesity. To evaluate the risk of cardiovascular diseases linked associated type 2 diabetes to that of a nondiabetic control group, as well as to investigate other correlations among stages of treatment and term of obesity also colorectal cancer danger.

Methods: Inside the Clinical Practice Research Datalink, researchers performed observed population-based prospective research (from May 2021–April 2022). Altogether individuals (17 years) having at least one medication for an anti-diabetic medicine (n = 305,045) were matched (1:1) by birth year, gender, in addition rehearsal to the control group that did not have diabetes. The relative risk ratios for colorectal cancer related to type 2 diabetes reported calculated using Cox proportional hazards models. Colorectal cancer correlations between treatment phases and persistence of obesity (BMI 32 kg/m2) have been evaluated in the diabetic population.

RESULTS: The diabetic research team had 2,762 instances of colorectal cancer after one average follow-up of 5.6 years. Type 2 diabetes has been linked to an elevated chance of developing colorectal cancer by 1.4 times (HR 1.27 [96% CI 1.19-1.34]). There was no correlation between treatment phases and diabetes individuals. Followed by periods of obesity that were linked to a higher likelihood of colorectal cancer. Individuals who had a history of obesity for 5-9 years (HR 1.18 [1.07-1.35]) and more than 9 years had a substantially higher chance of developing colorectal cancer (1.29 [1.12–1.48]).

Conclusion: TDM type-2 is linked to the slightly higher chance of developing colorectal cancer. Obesity has been linked to a greater likelihood of diabetes amongst diabetic individuals who had been obese for four years or more.

Keywords: Risk of Colorectal Cancer, Type 2 Diabetes, Obesity.